ProCE Banner Activity

Understanding the New Treatment Era of Alternative Therapies for Patients With Hemophilia A

Slideset Download
Downloadable slides with expert analysis on the use of EHL Factor VIII therapy for patients with hemophilia A.

Released: October 29, 2020

Expiration: October 28, 2021

Share

Faculty

Guy Young

Guy Young, MD

Director, Hemostasis and Thrombosis Center
Director, Clinical Coagulation Laboratory
Cancer and Blood Disorders Institute
Children’s Hospital Los Angeles
Professor of Pediatrics
Division of Hematology/Oncology
Department of Pediatrics
University of Southern California Keck School of Medicine
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Takeda Pharm USA

Faculty Disclosure

Primary Author

Guy Young, MD

Director, Hemostasis and Thrombosis Center
Director, Clinical Coagulation Laboratory
Cancer and Blood Disorders Institute
Children’s Hospital Los Angeles
Professor of Pediatrics
Division of Hematology/Oncology
Department of Pediatrics
University of Southern California Keck School of Medicine
Los Angeles, California

Guy A. Young, MD, has disclosed that he has received funds for research support from Genentech/Roche, Grifols, and Takeda; and consulting fees from BioMarin, Genentech/Roche, Grifols, Novo Nordisk, Sanofi, Spark, Takeda, and UniQure.